SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-004632
Filing Date
2023-01-18
Accepted
2023-01-18 16:46:31
Documents
6
Effectiveness Date
2023-01-18

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm233701d1_s8.htm S-8 58845
2 EXHIBIT 5.1 tm233701d1_ex5-1.htm EX-5.1 11665
3 EXHIBIT 23.2 tm233701d1_ex23-2.htm EX-23.2 2138
4 EX-FILING FEES tm233701d1_ex-filingfees.htm EX-FILING FEES 19636
5 GRAPHIC tm233701d1_ex5-1img01.jpg GRAPHIC 4221
6 GRAPHIC tm233701d1_ex5-1img02.jpg GRAPHIC 2664
  Complete submission text file 0001104659-23-004632.txt   103270
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269291 | Film No.: 23534928
SIC: 2836 Biological Products, (No Diagnostic Substances)